How to Store GLP-2/Tirz: Temperature, Shelf Life & Handling
Storage requirements for GLP-2/Tirz follow from what the molecule actually is — lipidated dual receptor agonist (gip / glp-1), 39-residue chain. The conditions below reflect that chemistry rather than generic peptide guidance.
Overview
Freezer for the powder, fridge once mixed, four to six weeks of use. Never freeze the mixed solution. The fatty chain attached to it gives good durability in storage — its weakness is physical handling, not time.
What GLP-2/Tirz actually is
GLP-2/Tirz is an engineered molecule acting on two receptors in the gut-hormone system involved in blood-sugar regulation. It carries a design detail that is very widely misreported: it was built on a GIP backbone and then modified to also engage GLP-1, whereas most compounds in its class went the other way round.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Storage conditions for GLP-2/Tirz
Why these conditions, specifically
Storage requirements for GLP-2/Tirz are set by its degradation chemistry rather than by a general rule for research peptides.
The main route to be aware of: interfacial aggregation from agitation or freezing — the dominant practical route.
All 3 degradation routes for GLP-2/TirzFreeze–thaw
Do not freeze reconstituted solution. Interfacial aggregation during freezing is the characteristic failure mode and is irreversible.
What GLP-2/Tirz is studied for
Simultaneous GIP and GLP-1 receptor activity from a GIP-derived backbone.
Core metabolic research endpoints for the incretin class.
A well-characterised GLP-1 pathway effect studied in metabolic models.
Whether GIP agonism or antagonism is the productive direction remains an active research debate.
Summarizes published preclinical literature — see the selected references below. Provided for research reference only; not a claim of efficacy or a description of human use.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. GLP-2/Tirz Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.
- Browse current GLP-2/Tirz literature on PubMed
References describe in-vitro and preclinical research and are listed for reference only — not evidence of efficacy and not a description of human use.
More GLP-2/Tirz reference
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Storage reference for other compounds
Reviewed for research-use compliance by Kobi Williams, Founder — Popular Peptides Canada. Last reviewed 22 July 2026.
GLP-2/Tirz is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.